Geode Capital Management LLC Raises Stock Position in Avanos Medical, Inc. (NYSE:AVNS)

Geode Capital Management LLC boosted its position in shares of Avanos Medical, Inc. (NYSE:AVNS) by 1.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,054,162 shares of the company’s stock after acquiring an additional 16,065 shares during the period. Geode Capital Management LLC’s holdings in Avanos Medical were worth $25,337,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of AVNS. Barclays PLC boosted its holdings in Avanos Medical by 446.2% in the third quarter. Barclays PLC now owns 96,194 shares of the company’s stock worth $2,311,000 after acquiring an additional 78,583 shares in the last quarter. Paradice Investment Management LLC boosted its stake in Avanos Medical by 5.4% in the 2nd quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock worth $26,791,000 after purchasing an additional 69,389 shares in the last quarter. Cornercap Investment Counsel Inc. purchased a new stake in Avanos Medical during the 2nd quarter worth approximately $1,077,000. FMR LLC increased its stake in Avanos Medical by 34.6% during the 3rd quarter. FMR LLC now owns 133,844 shares of the company’s stock valued at $3,216,000 after purchasing an additional 34,421 shares in the last quarter. Finally, Deerfield Management Company L.P. Series C purchased a new position in shares of Avanos Medical in the second quarter worth $551,000. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Avanos Medical Stock Down 1.5 %

Shares of AVNS stock opened at $15.92 on Friday. Avanos Medical, Inc. has a fifty-two week low of $15.77 and a fifty-two week high of $25.36. The firm has a market capitalization of $731.64 million, a PE ratio of 46.82 and a beta of 0.95. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The stock’s 50-day simple moving average is $19.14 and its 200-day simple moving average is $21.19.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.